Daxor (DXR) Short Interest Ratio & Short Volume

Short interest is the volume of Daxor shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 6,300 shares of DXR short. 0.30% of Daxor's shares are currently sold short. Learn More on Daxor's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of Daxor's floating shares are currently sold short.

Daxor saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 6,300 shares, a decrease of 42.2% from the previous total of 10,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Daxor currently has issued a total of 4,840,000 shares. Some of Daxor's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Daxor currently has a public float of 2,070,000 shares.

0.30% of Daxor's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Daxor: InfuSystem Holdings, Inc. (0.77%), Monogram Orthopaedics Inc. (1.62%), Inogen, Inc (3.35%), KORU Medical Systems, Inc. (3.14%), Profound Medical (2.17%), Electromed, Inc. (4.32%), LENSAR, Inc. (5.48%), TriSalus Life Sciences, Inc. (3.88%), Lakeland Industries, Inc. (12.54%), Avita Medical Inc. (23.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

Short selling DXR is an investing strategy that aims to generate trading profit from Daxor as its price is falling. DXR shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Daxor occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DXR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DXR, twice per month. The most recent reporting period available is July, 31 2025.